Aspirin is underused for the secondary prophylaxis of cardiovascular disease (CVD) in some long-term

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.374, 2002-01, pp. : 6-6

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Long-Term Prophylaxis in Bipolar Disorder

By Taylor Matthew J. Goodwin Guy M.

CNS Drugs, Vol. 20, Iss. 4, 2006-01 ,pp. : 303-310

Adis International

Access to resources Recommend Favorite

Long-term clopidogrel + aspirin beneficial after PCI

Inpharma, Vol. 1, Iss. 1366, 2002-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

Clopidogrel + aspirin beneficial for cardiovascular disease

Inpharma, Vol. 1, Iss. 1602, 2007-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Bezafibrate confers significant long-term cardiovascular protection among patients with coronary artery disease

Inpharma, Vol. 1, Iss. 1626, 2008-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite

Long-Term Consequences of Drugs on the Paediatric Cardiovascular System

By Hausner Elizabeth Fiszman Monica L. Hanig Joseph Harlow Patricia Zornberg Gwen Sobel Solomon

Drug Safety, Vol. 31, Iss. 12, 2008-01 ,pp. : 1083-1096

Adis International

Access to resources Recommend Favorite